SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-058607
Filing Date
2024-05-13
Accepted
2024-05-13 16:00:35
Documents
64
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alvr-20240331.htm   iXBRL 10-Q 1644958
2 EX-31.1 alvr-ex31_1.htm EX-31.1 14456
3 EX-31.2 alvr-ex31_2.htm EX-31.2 15340
4 EX-32.1 alvr-ex32_1.htm EX-32.1 8352
5 EX-32.2 alvr-ex32_2.htm EX-32.2 8390
  Complete submission text file 0000950170-24-058607.txt   6159378

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT alvr-20240331.xsd EX-101.SCH 909745
67 EXTRACTED XBRL INSTANCE DOCUMENT alvr-20240331_htm.xml XML 833578
Mailing Address 1100 WINTER STREET WALTHAM MA 02451
Business Address 1100 WINTER STREET WALTHAM MA 02451 (617) 433-2605
Allovir, Inc. (Filer) CIK: 0001754068 (see all company filings)

IRS No.: 831971007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39409 | Film No.: 24938833
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)